“Durable Complete Response in a Patient With BRAF-Mutated Advanced Melanoma With Ocular and Skin Toxicities from BRAF MEK Targeted Therapy After Immune Checkpoint Inhibitor Treatment: A Case Report”. Dermatology Reports (June 17, 2025). Accessed June 18, 2025. https://journals.pagepress.org/dr/article/view/10324.